Nobuhiko Fukuda
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita
|Feb 17, 2022
Adverse events induced by nivolumab and ipilimumab combination regimens.Kohei Somekawa, Nobuyuki Horita, Ayami Kaneko
|Dec 06, 2021
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa
|Nov 18, 2021
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.Nobuhiko Fukuda, Nobuyuki Horita, Ho Namkoong
Pageof 1
